亿帆医药(002019.SZ)：重酒石酸去甲肾上腺素注射用浓溶液获新加坡注册批文

Core Viewpoint - The company YiFan Pharmaceutical (002019.SZ) has received approval from the Health Sciences Authority (HSA) of Singapore for the market registration of its chemical drug, racemic norepinephrine injection solution, which is intended for the treatment of severe acute hypotension in adults [1] Group 1 - The company's subsidiary, SciGen Pte. Ltd., is responsible for the newly approved product [1] - The approved product is specifically designed to control blood pressure levels in adults experiencing severe acute hypotension [1]